[XENE] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
03-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -84.37%
YoY- -615.07%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 16 376 413 413 601 3,227 4,294 -97.58%
PBT -7,517 -6,004 -7,714 -6,016 -3,263 -3,937 -3,827 56.77%
Tax -470 542 383 -350 -2,395 1,334 3,007 -
NP -7,517 -6,004 -7,714 -6,016 -3,263 -3,937 -3,827 56.77%
Tax Rate - - - - - - - -
Total Cost 7,533 6,380 8,127 6,429 3,864 7,164 8,121 -4.88%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin -46,981.25 -1,596.81 -1,867.80 -1,456.66 -542.93 -122.00 -89.12 6400.95%
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -0.42 -0.33 -0.51 -0.42 -0.23 -0.27 -0.27 34.21%
EPS Diluted -0.42 -0.33 -0.51 -0.42 -0.23 -0.27 -0.27 34.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.